Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Medical Condition: Patients with confirmed COVID-19 infection and criteria for mild-moderate pneumonia (CURB-65 =1 i SatO2 =90%, MEWS score less than 3) and IL6 values of 20 pg / ml, will be randomly assigned to a sarilumab treatment group or another group receiving treatment according to the current therapeutic protocol of the PSMAR. MedDRA version: 21.1Level: PTClassification code 10035737Term: Pneumonia viralSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Patients+with+confirmed+COVID-19+infection+and+criteria+for+mild-moderate+pneumonia+%28CURB-65+%3D1+i+SatO2+%3D90%25%2C+MEWS+score+less+than+3%29+and+IL6+values+of+20+pg+%2F+ml%2C+will+be+randomly+assigned+to+a+sarilumab+treatment+group+or+another+group+receiving+treatment+according+to+the+current+therapeutic+protocol+of+the+PSMAR.+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10035737Term%3A+Pneumonia+viralSystem+Organ+Class%3A+10021881+-+Infections+and+infestations%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&lookfor=%22Sarilumab%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Patients+with+confirmed+COVID-19+infection+and+criteria+for+mild-moderate+pneumonia+%28CURB-65+%3D1+i+SatO2+%3D90%25%2C+MEWS+score+less+than+3%29+and+IL6+values+of+20+pg+%2F+ml%2C+will+be+randomly+assigned+to+a+sarilumab+treatment+group+or+another+group+receiving+treatment+according+to+the+current+therapeutic+protocol+of+the+PSMAR.+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10035737Term%3A+Pneumonia+viralSystem+Organ+Class%3A+10021881+-+Infections+and+infestations%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&lookfor=%22Sarilumab%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Patients+with+confirmed+COVID-19+infection+and+criteria+for+mild-moderate+pneumonia+%28CURB-65+%3D1+i+SatO2+%3D90%25%2C+MEWS+score+less+than+3%29+and+IL6+values+of+20+pg+%2F+ml%2C+will+be+randomly+assigned+to+a+sarilumab+treatment+group+or+another+group+receiving+treatment+according+to+the+current+therapeutic+protocol+of+the+PSMAR.+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10035737Term%3A+Pneumonia+viralSystem+Organ+Class%3A+10021881+-+Infections+and+infestations%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&lookfor=%22Sarilumab%22&type=Subject
PubPharm (2)
1
Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care : Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care - SARICOVID
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care : Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care - SARICOVID
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Patients with confirmed COVID-19 infection and criteria for mild-moderate pneumonia (CURB-65 =1 i SatO2 =90%, MEWS score less than 3) and IL6 values of 20 pg / ml, will be randomly assigned to a sarilumab treatment group or another group receiving treatment according to the current therapeutic protocol of the PSMAR. MedDRA version: 21.1Level: PTClassification code 10035737Term: Pneumonia viralSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Medienart
2
Aufsätze
2
E-Artikel
2
E-Ressourcen
Zeitschriftentitel
2
WHO International Clinical Trials Registry Plat...
Thema
2
610
Medical Condition: Patients with confirmed COVI...
2
Phase: Phase 3
2
Recruitment Status: Not yet recruiting
2
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2
Englisch
Haven't found what you're looking for?
Wird geladen...